ArticleOncogene2021

Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells.

Mitsuro Kanda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.